Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -26,050 | -20,545 | -12,860 | N/A |
| Depreciation Amortization | 39 | 83 | 2,185 | N/A |
| Accounts receivable | -374 | -135 | -30 | N/A |
| Accounts payable and accrued liabilities | 777 | 66 | 92 | N/A |
| Other Working Capital | 1,576 | -566 | 722 | N/A |
| Other Operating Activity | 939 | 2,808 | 1,916 | 0 |
| Operating Cash Flow | $-23,093 | $-18,289 | $-7,975 | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -9 | -158 | -13 | N/A |
| Investing Cash Flow | $-9 | $-158 | $-13 | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Repayment | N/A | -4,813 | -8,250 | N/A |
| Common Stock Issued | 65,138 | 13 | 59 | N/A |
| Other Financing Activity | 8,075 | 8,429 | 29,913 | 0 |
| Financing Cash Flow | $73,213 | $3,629 | $21,722 | $N/A |
| Beginning Cash Position | 7,202 | 22,020 | 8,286 | N/A |
| End Cash Position | 57,313 | 7,202 | 22,020 | N/A |
| Net Cash Flow | $50,111 | $-14,818 | $13,734 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -23,093 | -18,289 | -7,975 | N/A |
| Capital Expenditure | -9 | -158 | -13 | N/A |
| Free Cash Flow | -23,102 | -18,447 | -7,988 | 0 |